Tesaro
Tesaro is a biopharmaceutical company focused on identifying cancer therapies, acquired by GSK in 2019.
Acquisition Transaction
Acquirer
AngelList URL
B2X
CAGE Code
7G0C9
0
CEO
CFO
CIK Number
Legal Name
TESARO, Inc.
Company Operating Status
Active
Country
Crunchbase URL
Date Incorporated
March 26, 2010
DUNS Number
963385559
0
Email Address
contact@tesarobio.com
Facebook URL
Former CEO
Founded Date
March 1, 2010
Full Address
Five Moore Drive North Carolina 27709-3398 USA
0
23 Rochester Park Singapore 139234
0
5 Crescent Drive Philadelphia PA 19112 United States
0
980 Great West Road Brentford Middlesex TW8 9GS United Kingdom
0
Headquarters
Instagram URL
IRS Number
272,249,687
0
Latest Funding Round Date
April 18, 2016
Latest Funding Type
Legal classification
LinkedIn URL
Number of Employees (Ranges)
501 – 1,000
0
Patents Assigned (Count)
2
Phone Number
+18888255249
0
+6562328338
0
+442080475000
0
Pitchbook URL
Place of Incorporation
SIC Code
2,834
0
Exchange
Stock Symbol
TSRO
Total Funding Amount (USD)
457,000,000
Twitter URL
Official Website
Wellfound ID
Wikidata ID
YouTube Channel
Find more companies like Tesaro
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.